BioHealth News Archive
GlycoMimetics Enters Into Acquisition Agreement With Crescent Biopharma
ROCKVILLE, Md., October 29, 2024--(BUSINESS WIRE)--GlycoMimetics, Inc. (NASDAQ: GLYC) announced today it has entered into an acquisition agreement with Crescent Biopharma, Inc. ("Crescent"), a…
Read More
Gaithersburg’s Shuttle Pharma Doses First Patients in Phase 2 Clinical Trial of Ropidoxuridine for Treatment of Patients with Glioblastoma
GAITHERSBURG, Md., Oct. 29, 2024 (GLOBE NEWSWIRE) -- Shuttle Pharmaceuticals Holdings, Inc. (Nasdaq: SHPH) (“Shuttle Pharma”), a discovery and development stage specialty pharmaceutical company…
Read More
BioHub Maryland Opens New Biopharma Workforce Training Center in Montgomery County’s Life Sciences Corridor
ROCKVILLE, Md.--(BUSINESS WIRE)--BioHub Maryland, an initiative to accelerate life sciences in the state, today officially opened a new state-of-the-art biopharmaceutical workforce training center at…
Read More
BioHealth Innovation EIR Luis Gutierrez Moderates Key Life Sciences Panel at DC Start-Up & Technology Week
At Washington, D.C.’s recent Start-Up & Technology Week on October 25th, BioHealth Innovation’s Executive-in-Residence, Luis Gutierrez, led a pivotal panel as part of the…
Read More
Montgomery County Launches $10 Million Fund to Stimulate Job Growth for County-Based Companies in Cybersecurity, Hospitality, Life Sciences and Quantum Computing
For Immediate Release: Wednesday, October 23, 2024 - Montgomery County Executive Marc Elrich today announced the launch of a $10 million Job Creation Fund, a…
Read More
BHCR Finalist Chesapeake NeuroTech Among 71 Teams Advanced by NSF in Regional Innovation Engines Competition
The invited teams highlight the broad interest in the NSF Engines program and show great promise in building regional ecosystems that will accelerate breakthrough…
Read More
Sonavex Secures $15M Series A-2 Financing
Baltimore, MD (October 24th, 2024) – Sonavex, Inc., a privately held medical device company with ultrasound technologies that deliver quantitative blood flow and other…
Read More
TEDCO Announces Entrepreneur Expo Panel Focused on Advancing Women-Led Entrepreneurship in Maryland
COLUMBIA, Md., (October 24, 2024) –– TEDCO, Maryland’s economic engine for technology companies, announces the “Breaking Barriers and Building Futures: The Evolution of Women…
Read More
New Funding Secured to Support Clinical GMP Manufacturing Expansion at Rise Therapeutics
ROCKVILLE, Md., Oct. 23, 2024 /PRNewswire/ -- Rise Therapeutics announced today that it has received funding from the National Institute of Diabetes and Digestive and Kidney…
Read More
Biden-Harris Administration announces ARPA-H’s Sprint for Women’s Health awards aimed at closing gaps in women’s health research
The Advanced Research Projects Agency for Health (ARPA-H), an agency within the U.S. Department of Health and Human Services (HHS), today announced the teams…
Read More
Children’s National selected to receive $8 million award from ARPA-H’s Sprint for Women’s Health to advance device for precision pain measurement
WASHINGTON, D.C., Oct. 23, 2024 (GLOBE NEWSWIRE) -- Pain assessment in medicine often relies on imprecise visual rating scales featuring smiling or crying faces,…
Read More
Frederick’s Theradaptive Receives 2024 Best Technology in Spine Award by Orthopedics This Week
FREDERICK, Md., Oct. 23, 2024 /PRNewswire/ -- Theradaptive, a privately held, clinical stage biologics company developing protein therapeutics for spine, orthopedics, soft tissue repair and targeted…
Read More
United Therapeutics Corporation Announces the 500th Lung Transplant Utilizing its Centralized Ex Vivo Lung Perfusion Service
SILVER SPRING, Md. & JACKSONVILLE, Fla.--(BUSINESS WIRE)--United Therapeutics Corporation (Nasdaq: UTHR), a public benefit corporation, and its subsidiary Lung Bioengineering Inc. (LBE) announced that the…
Read More
TDR: BioHealth Capital Region Forum: A recap of innovation and collaboration
By: Tammi Thomas, Chief Development and Marketing Officer, TEDCO The 2024 BioHealth Capital Region Forum (BHCRF) once again solidified its position as the premier…
Read More
MacroGenics Enters Into Agreement With TerSera Therapeutics for the Sale of MARGENZA®
ROCKVILLE, Md. & DEERFIELD, Ill.--(BUSINESS WIRE)--Oct. 22, 2024-- MacroGenics, Inc. (NASDAQ: MGNX), a biopharmaceutical company focused on discovering, developing, manufacturing and commercializing innovative antibody-based therapeutics for the treatment…
Read More